SEC Form 4 · accession 0000899243-17-029061
G1 Therapeutics, Inc. · GTHX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
MedImmune Ventures, Inc.
10% Owner
Period of report
Dec 15, 2017
Accepted (ET)
Dec 18, 2017 · 5:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001560241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | Dec 15, 2017 | S | 200,000 | $19.75 | D | 2,950,630 | D |
Table II — derivative securities
No Table II lines on this filing.